The Matsuda index of the upper 3 BMI quartiles in the intervention group was significantly improved than in the control group at the 1-year mark (+1.1 ± 3.0 vs. -0.2 ± 3.6; p = 0.026), although there was no difference in the lowest BMI quartile between groups (+1.3 ± 3.4 vs. +1.0 ± 3.7; p = 0.702).
Furthermore, Costa-Giomi [43] found that children receiving piano lessons improved more than controls in visual-spatial skills over the first two years of instruction, but the controls caught up with the experimental group by the end of the third year.
The results indicate that the experimental therapy is significantly better than control in improving the tolerance to peanut flour in patients with peanut allergy.
The explanation provided for this possible outcome is that participants in the waitlist control arm improve less than controls in non-waitlist designs as there is an expectation they are to "wait to change" until they receive the intervention [ 44].
This reduction reflects a rise in deaths attributable to smoking rather than improved tuberculosis control.
Specific treatment for the underlying nerve damage is currently not available, other than improved glycemic control, which may modestly slow progression (79) but not reverse neuronal loss.
Specific treatment for the underlying nerve damage is currently not available, other than improved glycemic control, which may slow progression but not reverse neuronal loss.
Indeed, blood pressure reduction probably has a greater impact on cardiovascular disease than improved glycemic control, yet it is often considered a secondary priority (5– 7).
Specific treatment for the underlying nerve damage is not currently available, other than improved glycemic control, which may slow progression but not reverse neuronal loss.
Furthermore, aggressive management of blood glucose levels per se does not substantially improve most cardiovascular risk factors commonly present in T2DM, including obesity, hypertension or diabetic dyslipidemia indicating that CVD risk management in T2DM requires more than improved glucose control.
